Healthcare provider profile · identity verified

Edward C Wolf, M.D.

Internal Medicine · CORVALLIS, OR · NPI 1336190875

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	548	192
Levothyroxine Sodium	Levothyroxine Sodium	481	147
Losartan Potassium	Losartan Potassium	439	142
Metoprolol Succinate	Metoprolol Succinate	403	124
Amlodipine Besylate	Amlodipine Besylate	369	115
Eliquis	Apixaban	297	56
Gabapentin	Gabapentin	257	67
Simvastatin	Simvastatin	253	74
Tamsulosin Hcl	Tamsulosin Hcl	193	60
Omeprazole	Omeprazole	183	64
Furosemide	Furosemide	179	47
Lisinopril	Lisinopril	166	56
Hydrochlorothiazide	Hydrochlorothiazide	163	51
Pantoprazole Sodium	Pantoprazole Sodium	154	47
Trazodone Hcl	Trazodone Hcl	138	29
Warfarin Sodium	Warfarin Sodium	135	33
Alendronate Sodium	Alendronate Sodium	134	39
Escitalopram Oxalate	Escitalopram Oxalate	130	41
Metformin Hcl Er	Metformin Hcl	118	34
Metformin Hcl	Metformin Hcl	114	36
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	111	42
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	103	33
Potassium Chloride	Potassium Chloride	103	27
Sertraline Hcl	Sertraline Hcl	98	28
Carvedilol	Carvedilol	96	26
Donepezil Hcl	Donepezil Hcl	84	17
Allopurinol	Allopurinol	70	22
Metoprolol Tartrate	Metoprolol Tartrate	70	27
Clopidogrel	Clopidogrel Bisulfate	69	21
Zolpidem Tartrate	Zolpidem Tartrate	68	22
Chlorthalidone	Chlorthalidone	66	24
Bupropion Xl	Bupropion Hcl	65	14
Rosuvastatin Calcium	Rosuvastatin Calcium	64	21
Jardiance	Empagliflozin	62	11
Diclofenac Sodium	Diclofenac Sodium	60	24
Citalopram Hbr	Citalopram Hydrobromide	52	13
Finasteride	Finasteride	49	18
Pravastatin Sodium	Pravastatin Sodium	47	12
Lovastatin	Lovastatin	45	14
Oxybutynin Chloride Er	Oxybutynin Chloride	42	14
Lorazepam	Lorazepam	41	20
Myrbetriq	Mirabegron	40	suppressed
Duloxetine Hcl	Duloxetine Hcl	38	suppressed
Oxycodone Hcl	Oxycodone Hcl	38	15
Testosterone Cypionate	Testosterone Cypionate	36	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	35	31
Pregabalin	Pregabalin	34	11
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Atenolol	Atenolol	33	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	11
Ibandronate Sodium	Ibandronate Sodium	33	suppressed
Memantine Hcl	Memantine Hcl	33	suppressed
Ozempic	Semaglutide	32	suppressed
Alprazolam	Alprazolam	30	17
Synthroid	Levothyroxine Sodium	30	suppressed
Xarelto	Rivaroxaban	28	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	26	20
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Torsemide	Torsemide	26	suppressed
Glipizide	Glipizide	25	suppressed
Acyclovir	Acyclovir	23	13
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Prednisone	Prednisone	23	suppressed
Lamotrigine	Lamotrigine	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Primidone	Primidone	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Telmisartan	Telmisartan	19	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	18	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Mupirocin	Mupirocin	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Spironolactone	Spironolactone	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Famotidine	Famotidine	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Tramadol Hcl	Tramadol Hcl	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	12
Amoxicillin	Amoxicillin	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Brilinta	Ticagrelor	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Metolazone	Metolazone	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Dilantin	Phenytoin Sodium Extended	12	suppressed
Nystatin	Nystatin	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Baclofen	Baclofen	11	suppressed
Estradiol	Estradiol	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error